$BLUE stock has now risen 27% today, according to our price data from Polygon. There has been approximately $12,540,691 of trading volume.
Here is what we see in our data on $BLUE:$BLUE Insider Trading Activity
$BLUE insiders have traded $BLUE stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $BLUE stock by insiders over the last 6 months:
- ANDREW OBENSHAIN (President and CEO) has made 0 purchases and 4 sales selling 35,977 shares for an estimated $20,604.
- RICHARD A COLVIN (Chief Medical Officer) has made 0 purchases and 4 sales selling 3,491 shares for an estimated $4,116.
- THOMAS J KLIMA (See Remarks) has made 0 purchases and 3 sales selling 1,628 shares for an estimated $3,390.
- JOSEPH VITTIGLIO (Chief Business & Legal Officer) sold 238 shares for an estimated $1,759
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BLUE Hedge Fund Activity
We have seen 8 institutional investors add shares of $BLUE stock to their portfolio, and 124 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 772,190 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $6,440,064
- VANGUARD GROUP INC removed 523,700 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $4,367,658
- AMERIPRISE FINANCIAL INC removed 319,582 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $3,320,456
- GEODE CAPITAL MANAGEMENT, LLC removed 234,152 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,952,827
- STATE STREET CORP removed 192,096 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,602,080
- FMR LLC removed 124,098 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,034,977
- UBS GROUP AG added 101,346 shares (+2044.9%) to their portfolio in Q4 2024, for an estimated $845,225
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BLUE Analyst Ratings
Wall Street analysts have issued reports on $BLUE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 12/31/2024
To track analyst ratings and price targets for $BLUE, check out Quiver Quantitative's $BLUE forecast page.
You can track data on $BLUE on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
